Chelsea Black, PhD, ABPP-CN, is a board-certified pediatric neuropsychologist in the Neuropsychology and Assessment Program at the Children’s Hospital of Philadelphia (CHOP). She also serves as the supervising neuropsychologist in the Behavioral Neuroscience Core of CHOP’s Center for Human Phenomic Science. She has clinical and research interests in the disruption of mood, language, and executive function processes in pediatric medical disorders, with a particular interest in multiple sclerosis and other neuroinflammatory disorders.
Lauren Demers, PhD, is a pediatric neuropsychologist in the Neuropsychology and Assessment Program at the Children’s Hospital of Philadelphia (CHOP). She provides outpatient neuropsychological consultation and evaluations to pediatric patients with a broad range of medical diagnoses. She has a specific practice focus on increasing access to neuropsychological care.
Sophie Foss, PhD, is a pediatric neuropsychologist in the Neuropsychology and Assessment Program at the Children’s Hospital of Philadelphia (CHOP). She is primarily affiliated with the Congenital Hyperinsulinism Center and the Craniofacial Program, where she provides consultation and assessment services for infants, children, and adolescents. Her clinical interests include neuropsychological development in children with congenital disorders, early childhood assessment, and epilepsy. Her research interests include developmental and fetal origins of brain health and neurocognitive functioning, identification of early predictors of neurodevelopmental outcomes, and the development of executive control and self-regulation capacity in children.
Karen Blanc Friedman, PhD, is a clinical psychologist in the Neuropsychology and Assessment Program at the Children’s Hospital of Philadelphia (CHOP). With extensive experience in early childhood psychological and developmental assessments, she has worked in various roles within the hospital to support diverse patient populations. As a native Spanish speaker from Peru, Karen has developed a deep understanding of the linguistic and cultural considerations necessary for accurate psychological testing. She was involved in a research study aimed at validating a widely used developmental screening instrument in Spanish, and she has worked closely with the Hispanic community in Philadelphia. Karen has also been a guest presenter on these topics at CHOP as well as other academic and health institutions in the region.
Hannah-Lise Tirado Schofield, PhD, ABPP-CN, is a board-certified pediatric neuropsychologist in the Neuropsychology and Assessment Program at the Children’s Hospital of Philadelphia (CHOP). She is primarily affiliated with CHOP’s Cancer Center, where she conducts evaluations with children and adolescents during various stages of cancer treatment, including patients followed within the Childhood Cancer Survivorship Program. Hannah is a bilingually-raised (Spanish and English) provider who is committed to providing thoughtful care to bilingual patients within the Cancer Center. She has a primary clinical and research interest in the neuropsychological outcomes of hematopoietic stem cell transplant and CAR T-cell therapy. Hannah is the director of the Neuropsychology Fellowship at CHOP.
Learning Objectives:
- Describe methods of standardized assessment during developmental or neuropsychological assessments
- Describe proposed process for preparation and pre-planning with evaluating psychologist/neuropsychologist
- Explore potential challenges and opportunities for collaboration during evaluation process
Speakers:
- Chelsea Black, PhD, ABPP-CN
- Lauren Demers, PhD
- Sophie Foss, PhD
- Karen Blanc Friedman, PhD
- Hannah-Lise Tirado Schofield, PhD, ABPP-CN
This seminar was delivered for the Language Services Interpreter’s Roundtable Session on March 12, 2025.
Content Disclaimer
The Terms of Use and Privacy Policy set forth on the website of The Children’s Hospital of Philadelphia apply to any and all uses of and access to this site and the content found here.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.
Course Includes
- 1 Lesson
- Course Certificate